Literature DB >> 16143521

Synthesis and evaluation of 3-anilino-quinoxalinones as glycogen phosphorylase inhibitors.

Joseph Dudash1, Yongzheng Zhang, John B Moore, Richard Look, Yin Liang, Mary Pat Beavers, Bruce R Conway, Philip J Rybczynski, Keith T Demarest.   

Abstract

A series of 3-anilino-quinoxalinones has been identified as a new class of glycogen phosphorylase inhibitors. The lead compound 1 was identified through high throughput screening as well as through pharmacophore-based electronic screening. Modifications were made to the scaffold of 1 to produce novel analogues, some of which are 25 times more potent than the lead compound.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16143521     DOI: 10.1016/j.bmcl.2005.07.021

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Concise route to a series of novel 3-(tetrazol-5-yl)quinoxalin-2(1H)-ones.

Authors:  Steven Gunawan; Gary Nichol; Christopher Hulme
Journal:  Tetrahedron Lett       Date:  2012-01-28       Impact factor: 2.415

2.  Regioselective C-3-alkylation of quinoxalin-2(1H)-ones via C-N bond cleavage of amine derived Katritzky salts enabled by continuous-flow photoredox catalysis.

Authors:  Gandhari Kishor; Vankudoth Ramesh; Vadithya Ranga Rao; Srihari Pabbaraja; Praveen Reddy Adiyala
Journal:  RSC Adv       Date:  2022-04-29       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.